The Effect of an App-based Intervention on Quality of Life in Patients With Endometriosis.
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorInsel Gruppe AG, University Hospital Bern
About this trial
The goal of this clinical trial is to learn if an App-based intervention affects the quality of life in patients with suspected or confirmed endometriosis. The main questions it aims to answer are:
* Does the App-based intervention improve the quality of life? * Does it lead to pain relief? Researchers will compare participants using the App to a control group to see if the App works to improve quality of life and endometriosis-related symptoms.
Participants will:
* Use an App-based intervention or be in the control group (no App-use) for 6 months * Visit or have a telephone consultation after 3 and 6 months * Complete a questionnaire to assess the quality of life at inclusion, after 1, 3 and 6 months
Eligibility criteria
Qualifiers
Informed Consent as documented by signature
Age 18 or older
Premenopausal status (menopause is defined as amenorrhea lasting one year or longer)
Endometriosis, confirmed by surgery or clinically suspected
Disqualifiers
Planned endometriosis surgery or planned hormonal therapy in the study period
Surgery and/or new hormonal therapy in the last three months
Malignant diseases
Pregnancy
Trial design
Treatments tested in this trial
- NALU Endo Flow App
Treatment groups
308 Participants
are divided into 4 treatment groupsLocations
1Department of Gynecology and Obstetrics, Women's University Hospital, Inselspital Bern, University of Bern3010, Bern Switzerland
Sponsors and collaborators
Insel Gruppe AG, University Hospital Bern
Lead sponsor
Source ClinicalTrials.gov